View Item 

Show simple item record

Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials

dc.contributor.authorMeza, Rafaelen_US
dc.contributor.authorHaaf, Kevinen_US
dc.contributor.authorKong, Chung Yinen_US
dc.contributor.authorErdogan, Aycaen_US
dc.contributor.authorBlack, William C.en_US
dc.contributor.authorTammemagi, Martin C.en_US
dc.contributor.authorChoi, Sung Eunen_US
dc.contributor.authorJeon, Jihyounen_US
dc.contributor.authorHan, Summer S.en_US
dc.contributor.authorMunshi, Viditen_US
dc.contributor.authorRosmalen, Joosten_US
dc.contributor.authorPinsky, Paulen_US
dc.contributor.authorMcMahon, Pamela M.en_US
dc.contributor.authorKoning, Harry J.en_US
dc.contributor.authorFeuer, Eric J.en_US
dc.contributor.authorHazelton, William D.en_US
dc.contributor.authorPlevritis, Sylvia K.en_US
dc.date.accessioned2014-05-23T15:58:59Z
dc.date.availableWITHHELD_14_MONTHSen_US
dc.date.available2014-05-23T15:58:59Z
dc.date.issued2014-06-01en_US
dc.identifier.citationMeza, Rafael; Haaf, Kevin; Kong, Chung Yin; Erdogan, Ayca; Black, William C.; Tammemagi, Martin C.; Choi, Sung Eun; Jeon, Jihyoun; Han, Summer S.; Munshi, Vidit; Rosmalen, Joost; Pinsky, Paul; McMahon, Pamela M.; Koning, Harry J.; Feuer, Eric J.; Hazelton, William D.; Plevritis, Sylvia K. (2014). "Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials." Cancer 120(11): 1713-1724.en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106827
dc.publisherAgency for Healthcare Research and Qualityen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCancer Intervention and Surveillance Modeling Network (CISNET)en_US
dc.subject.otherComparative Modeling Analysesen_US
dc.subject.otherLow‐Dose CT Screeningen_US
dc.subject.otherCancer Natural History Modelsen_US
dc.subject.otherSmoking and Lung Canceren_US
dc.subject.otherSimulation Modelen_US
dc.subject.otherLung Cancer Screeningen_US
dc.titleComparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106827/1/cncr28623.pdf
dc.identifier.doi10.1002/cncr.28623en_US
dc.identifier.sourceCanceren_US
dc.identifier.citedreferenceTammemagi MC, Lam SC, McWilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila). 2011; 4: 552 ‐ 561.en_US
dc.identifier.citedreferenceNational Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung‐cancer mortality with low‐dose computed tomographic screening. N Engl J Med. 2011; 365: 395 ‐ 409.en_US
dc.identifier.citedreferenceOken MM, Hocking WG, Kvale PA, et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011; 306: 1865 ‐ 1873.en_US
dc.identifier.citedreferenceBach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418 ‐ 2429.en_US
dc.identifier.citedreferenceBach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012; 157: 571 ‐ 573.en_US
dc.identifier.citedreferenceMoolgavkar SH, Holford TR, Levy DT, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975‐2000. J Natl Cancer Inst. 2012; 104: 541 ‐ 548.en_US
dc.identifier.citedreferenceZauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long‐term prevention of colorectal‐cancer deaths. N Engl J Med. 2012; 366: 687 ‐ 696.en_US
dc.identifier.citedreferenceMandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009; 151: 738 ‐ 747.en_US
dc.identifier.citedreferenceEtzioni R, Gulati R, Tsodikov A, et al. The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer. 2012; 118: 5955 ‐ 5963.en_US
dc.identifier.citedreferenceHeijnsdijk EA, Wever EM, Auvinen A, et al. Quality‐of‐life effects of prostate‐specific antigen screening. N Engl J Med. 2012; 367: 595 ‐ 605.en_US
dc.identifier.citedreferenceFeuer EJ, Etzioni R, Cronin KA, Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004; 13: 421 ‐ 442.en_US
dc.identifier.citedreferenceKuntz KM, Lansdorp‐Vogelaar I, Rutter CM, et al. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making. 2011; 31: 530 ‐ 539.en_US
dc.identifier.citedreferenceMcMahon PM, Hazelton WD, Kimmel M, Clarke LD. Chapter 13: CISNET lung models: comparison of model assumptions and model structures. Risk Anal. 2012; 32 ( suppl 1 ): S166 ‐ S178.en_US
dc.identifier.citedreferenceWeinstein MC, O'Brien B, Hornberger J, et al; ISPOR Task Force on Good Research Practices‐Modeling Studies. Principles of good practice for decision analytic modeling in health‐care evaluation: report of the ISPOR Task Force on Good Research Practices‐Modeling Studies. Value Health. 2003; 6: 9 ‐ 17.en_US
dc.identifier.citedreferenceMcMahon PM, Kong CY, Johnson BE, et al. Estimating long‐term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008; 248: 278 ‐ 287.en_US
dc.identifier.citedreferenceMcMahon PM, Kong CY, Johnson BE, et al. Chapter 9: the MGH‐HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012; 32 ( suppl 1 ): S117 ‐ S124.en_US
dc.identifier.citedreferenceMeza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the Nurses' Heath and the Health Professionals' Follow‐Up Studies using a multistage carcinogenesis model. Cancer Causes Control. 2008; 19: 317 ‐ 328.en_US
dc.identifier.citedreferenceHazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in 3 cohorts. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1171 ‐ 1181.en_US
dc.identifier.citedreferenceHazelton WD, Goodman G, Rom WN, et al. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers. Math Biosci. 2012; 240: 20 ‐ 34.en_US
dc.identifier.citedreferenceSchollnberger H, Manuguerra M, Bijwaard H, et al. Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi‐stage cancer model. Carcinogenesis. 2006; 27: 1432 ‐ 1444.en_US
dc.identifier.citedreferenceSpitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007; 99: 715 ‐ 726.en_US
dc.identifier.citedreferenceSiebert U, Alagoz O, Bayoumi AM, et al. State‐transition modeling: a report of the ISPOR‐SMDM Modeling Good Research Practices Task Force‐3. Med Decis Making. 2012; 32: 690 ‐ 700.en_US
dc.identifier.citedreferenceJeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Chapter 5: actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Anal. 2012; 32 ( suppl 1 ): S51 ‐ S68.en_US
dc.identifier.citedreferenceRosenberg MA, Feuer EJ, Yu B, et al. Chapter 3: cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal. 2012; 32 ( suppl 1 ): S25 ‐ S38.en_US
dc.identifier.citedreferenceMacMahon H, Austin JH, Gamsu G, et al; Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005; 237: 395 ‐ 400.en_US
dc.identifier.citedreferenceRutter CM, Zaslavsky AM, Feuer EJ. Dynamic microsimulation models for health outcomes: a review. Med Decis Making. 2011; 31: 10 ‐ 18.en_US
dc.identifier.citedreferenceHaiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking‐related risk of lung cancer. N Engl J Med. 2006; 354: 333 ‐ 342.en_US
dc.identifier.citedreferenceKenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA. Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control. 2008; 17: 198 ‐ 204.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention (CDC). Smoking‐attributable mortality, years of potential life lost, and productivity losses‐United States, 2000‐2004. MMWR Morb Mortal Wkly Rep. 2008; 57: 1226 ‐ 1228.en_US
dc.identifier.citedreferenceHumphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low‐dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med. 2013; 159: 411 ‐ 420.en_US
dc.identifier.citedreferencede Koning HJ, Meza R, Plevritis SK, et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Programs for High‐Risk Populations. AHRQ Pub. No. 13‐05196‐EF‐2. Rockville, MD: Agency for Healthcare Research and Quality; 2013.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr28623.pdf
Size:
686.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.